Metabolic Signatures for Liver Cancer Diagnosis and Mechanistic Insights: A Large‐Scale, Multicenter Study

Yongjie Xu, Jiachen Wang, Chunmeng Ding, Changfa Xia, Yunyong Liu, Yuanjie Zheng, Sheng Chang, Shaokai Zhang, Yutong He, Ruifang Sun, Yunfeng Xi, Yan Liu, Kun Qian, Wanqing Chen · 2026

Read Metabolic Signatures for Liver Cancer Diagnosis and Mechanistic Insights: A Large‐Scale, Multicenter Study by Yongjie Xu, Jiachen Wang, Chunmeng Ding, Changfa Xia, Yunyong Liu, Yuanjie Zheng, Sheng Chang, Shaokai Zhang, Yutong He, Ruifang Sun, Yunfeng Xi, Yan Liu, Kun Qian, Wanqing Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634481.txt.

Description

Yongjie Xu and co-authors build a blood metabolite test for liver cancer in a 2026 study. Early detection is the weakest link in this cancer's poor outlook. Serum from 1,924 people across eleven centers trains a nine-metabolite signature, read by a nanoparticle boosted mass method. A further 225 people at two centers validate it. Paired with the standard alpha-fetoprotein marker, accuracy runs high in both cohorts.

Early stage cancers are caught with good sensitivity, they report, and the main liver cancer type scores best. One metabolite, nicotinamide, also shows a causal hint for cancer risk. Lab work shows it feeds tumor cell growth and spread through an energy pathway.

Catalog record

CREATORYongjie Xu, Jiachen Wang, Chunmeng Ding, Changfa Xia, Yunyong Liu, Yuanjie Zheng, Sheng Chang, Shaokai Zhang, Yutong He, Ruifang Sun, Yunfeng Xi, Yan Liu, Kun Qian, Wanqing Chen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13634481

Browse the full library · About the Tower of Babel